Description
The most common type of primary liver cancer is hepatocellular carcinoma (HCC), which arises from hepatocytes, the main functional cells of the liver. Other types include intrahepatic cholangiocarcinoma, which originates in the bile ducts within the liver, and rare forms such as angiosarcoma. In addition, the liver is a frequent site for metastatic cancers that originate elsewhere in the body.
Major risk factors for liver cancer include chronic infection with hepatitis B or hepatitis C viruses, long-term alcohol use leading to cirrhosis, and non-alcoholic fatty liver disease associated with obesity and diabetes. Other contributors include exposure to aflatoxins, certain genetic liver disorders, and long-standing liver inflammation or scarring.
Early symptoms are often vague or absent, which contributes to delayed diagnosis. When symptoms do occur, they may include unexplained weight loss, fatigue, loss of appetite, abdominal discomfort or swelling, jaundice (yellowing of the skin and eyes), and pain in the upper right side of the abdomen or shoulder.
Diagnosis typically involves blood tests, including liver function tests and alpha-fetoprotein (AFP) levels, along with imaging studies such as ultrasound, CT scans, or MRI. In some cases, a liver biopsy may be performed to confirm the diagnosis, although imaging findings in combination with risk factors can sometimes be sufficient for diagnosis.
Treatment options depend on the stage of the cancer and the underlying liver function. Curative approaches may include surgical resection or liver transplantation in select cases, while localized therapies such as radiofrequency ablation, chemoembolization, or radioembolization may be used for non-surgical candidates. Systemic therapies are used for advanced disease.
Advances in targeted therapy and immunotherapy have improved treatment options for patients with advanced liver cancer. Drugs that inhibit tumor growth pathways and immune checkpoint inhibitors have shown benefit in selected cases, offering new hope where traditional chemotherapy was less effective. Clinical trials continue to expand these options.
Living with liver cancer often requires management of both the cancer and underlying liver disease. Patients may need dietary adjustments, medication for symptom control, and careful monitoring of liver function. Multidisciplinary care involving oncologists, hepatologists, and supportive care teams plays a central role in improving quality of life and treatment outcomes.
Details
Publisher - Xspurts.com
Language - English
Perfect Bound
Contributors
By author
Wyatt U. Sinclair
Published Date - 2026-05-27
ISBN - 9781776829972
Dimensions - 19.7 x 13.2 x 1.1 cm
Page Count - 200
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.